BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma YJ, Cao ZX, Li Y, Feng SY. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(21): 2675-2682 [PMID: 31210718 DOI: 10.3748/wjg.v25.i21.2675]
URL: https://www.wjgnet.com/1948-5182/full/v25/i21/2675.htm
Number Citing Articles
1
Wansheng Yan, Zhihui Yao, Qiutong Ou, Gang Ye. Establishment and validation of a prognosis nomogram for MIMIC-III patients with liver cirrhosis complicated with hepatic encephalopathyBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02967-1
2
Rui Dai, Alan A. Sag, Jonathan G. Martin, Nicholas T. Befera, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Andrew J. Muir, James Ronald. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohortClinical Imaging 2021; 77: 187 doi: 10.1016/j.clinimag.2021.04.034
3
Naina Mohamed Pakkir Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump InhibitorsChonnam Medical Journal 2023; 59(2): 115 doi: 10.4068/cmj.2023.59.2.115
4
Lindsey Sellers Coppiano, Dianne May. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2020; 42: 361 doi: 10.1016/bs.seda.2020.08.012
5
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Yoshihisa Arao, Toru Setsu, Hiroteru Kamimura, Nobuo Waguri, Manabu Takeuchi, Kazuhiro Funakoshi, Shuji Terai. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitorsMedicine 2021; 100(32): e26902 doi: 10.1097/MD.0000000000026902
6
Mitchell L. Schubert. Proton pump inhibitorsCurrent Opinion in Gastroenterology 2019; 35(6): 509 doi: 10.1097/MOG.0000000000000580
7
Mohammad Amin Fallahzadeh, Robert S. Rahimi. Hepatic Encephalopathy and Nutrition Influences: A Narrative ReviewNutrition in Clinical Practice 2020; 35(1): 36 doi: 10.1002/ncp.10458
8
Xiucong Fan, Danxia Chen, Siwei Bao, Xiaohui Dong, Fang Fang, Rong Bai, Yuyi Zhang, Xiaogang Zhang, Weijun Tang, Yabin Ma, Xiaobo Zhai. Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort studyBMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09931-5
9
Richard Moreau, Marta Tonon, Aleksander Krag, Paolo Angeli, Marina Berenguer, Annalisa Berzigotti, Javier Fernandez, Claire Francoz, Thierry Gustot, Rajiv Jalan, Maria Papp, Jonel Trebicka. EASL Clinical Practice Guidelines on acute-on-chronic liver failureJournal of Hepatology 2023; 79(2): 461 doi: 10.1016/j.jhep.2023.04.021
10
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liverJournal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
11
Mohammad Amin Fallahzadeh, Robert S. Rahimi. Hepatic Encephalopathy: Current and Emerging Treatment ModalitiesClinical Gastroenterology and Hepatology 2022; 20(8): S9 doi: 10.1016/j.cgh.2022.04.034
12
L. Veremme, A. Baudouin, A. Janoly-Dumenil, B. Charpiat. Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protonsAnnales Pharmaceutiques Françaises 2023; 81(3): 552 doi: 10.1016/j.pharma.2022.11.006
13
Rok Orel, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Alexandra Papadopoulou, Carmen Ribes-Koninckx, Mike Thomson, Michael Wilschanski, Nikhil Thapar. Drugs in Focus: Proton Pump InhibitorsJournal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 645 doi: 10.1097/MPG.0000000000003063
14
Vincenzo Savarino, Elisa Marabotto, Manuele Furnari, Fabiana Zingone, Patrizia Zentilin, Edoardo Savarino. Latest insights into the hot question of proton pump inhibitor safety – a narrative reviewDigestive and Liver Disease 2020; 52(8): 842 doi: 10.1016/j.dld.2020.04.020
15
Yun Hong, Ziqi Ye, Zhe Gao, Yuefeng Rao. Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospitalJournal of International Medical Research 2020; 48(10): 030006052095472 doi: 10.1177/0300060520954729
16
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studiesBioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
17
Rong-Qiang Liu, Yi Shao. Results of meta-analysis should be treated criticallyWorld Journal of Gastroenterology 2020; 26(9): 992-994 doi: 10.3748/wjg.v26.i9.992
18
Mitchell L. Schubert. Proton pump inhibitors: misconceptions and proper prescribing practiceCurrent Opinion in Gastroenterology 2020; 36(6): 493 doi: 10.1097/MOG.0000000000000676
19
Reidar Fossmark, Tom C. Martinsen, Helge L. Waldum. Adverse Effects of Proton Pump Inhibitors—Evidence and PlausibilityInternational Journal of Molecular Sciences 2019; 20(20): 5203 doi: 10.3390/ijms20205203
20
倩倩 何. Research Progress on Risk Factors of Hepatic Encephalopathy after TIPSAdvances in Clinical Medicine 2023; 13(10): 15870 doi: 10.12677/ACM.2023.13102218